Skip to main content
. Author manuscript; available in PMC: 2017 Aug 16.
Published in final edited form as: J Viral Hepat. 2016 Aug 11;23(12):1009–1016. doi: 10.1111/jvh.12580

TABLE 4.

Logistic regression of odds of treatment completion and SVR among 200 patients who commenced hepatitis C treatment in prison and stratified by genotype

Patient characteristics Odds of completing treatment
Odds of achieving a SVR
Adjusted odds ratio P valueb Adjusted odds ratio P value
All genotypes
 Major HCV genotype
  1 or 4 1 1
  2 or 3 1.75 (0.85, 3.58) .13 2.09 (1.12. 3.90) .02
 Cirrhosis3
  No 1 1
  Yes 0.16 (0.03, 0.81) .03 0.31 (0.06, 1.46) .14
 Movement during treatment
  None 1 1
  Transferred but not released 0.41 (0.17, 1.00) .05 0.58 (0.26, 1.27) .18
  Released (+/− transfer) 0.10 (0.04, 0.24) <.01 0.33 (0.15, 0.71) <.01

Genotype 1/4
 Cirrhosis3
  No 1 1
  Yes 0.33 (0.19, 5.89) .45 0.50 (0.29, 8.71) .63
 Movement during treatment
  None 1 1
  Transferred but not released 1.17 (0.30, 4.47) .82 0.50 (0.16, 1.59) .24
  Released (+/− transfer) 0.17 (0.05, 0.54) <.01 0.25 (0.08, 0.78) .02

Genotype 2/3
 Cirrhosis3
  No 1 1
  Yes 0.12 (0.01, 0.97) .05 0.24 (0.04, 1.52) .13
 Movement during treatment
  None 1 1
  Transferred but not released 0.17 (0.05, 0.56) <.01 0.66 (0.22, 1.99) .46
  Released (+/− transfer) 0.06 (0.02, 0.23) <.01 0.43 (0.14, 1.31) .14
a

At the time of treatment commencement.

b

P values in bold type denote statistical significance at P <0.05.